Can Trazodone Induce Mania?
Yes, trazodone can induce mania or hypomania, particularly in patients with bipolar disorder or those at risk for mood switching, though the risk appears relatively low, especially at lower doses used for sleep. 1
FDA-Labeled Warning
The FDA drug label explicitly warns that "in patients with bipolar disorder, treating a depressive episode with Trazodone Hydrochloride Tablets or another antidepressant may precipitate a mixed/manic episode. Activation of mania/hypomania has been reported in a small proportion of patients with major affective disorder who were treated with antidepressants." 1 The label mandates screening patients for any personal or family history of bipolar disorder, mania, or hypomania prior to initiating treatment. 1
Risk Stratification by Dose and Clinical Context
Higher Risk Scenarios:
- Antidepressant doses (150-300 mg/day) without mood stabilizer co-therapy carry the primary risk of manic switching 2
- Patients with undiagnosed or untreated bipolar disorder are at elevated risk 1
- Combination with other antidepressants (e.g., SSRIs) may increase affective lability and switching risk 3, 4
Lower Risk Scenarios:
- Low doses (50-150 mg) used for hypnotic/sedative effects appear safer, with manic episodes occurring primarily in patients with other risk factors 2
- Combination with mood stabilizers shows no evidence of increased switching risk for trazodone 2
- Unipolar depression without bipolar risk factors has lower switching liability 2
Clinical Evidence
Case reports document manic episodes following trazodone initiation, including a patient on stable sertraline who switched to mania after adding trazodone for sleep 4, and another on escitalopram who developed mania when trazodone was added 3. However, a systematic review found that low-dose trazodone used for sleep promotion caused mania only in patients with other risk factors for switching. 2
Notably, the American Academy of Child and Adolescent Psychiatry guidelines state that "antidepressants may destabilize the patient's mood or incite a manic episode" and that "a manic episode precipitated by an antidepressant is characterized as substance induced per DSM-IV-TR." 5
Clinical Management Algorithm
Before prescribing trazodone:
- Screen for personal or family history of bipolar disorder, mania, or hypomania 1
- Assess for prior antidepressant-induced mood destabilization 5
If prescribing for sleep in bipolar patients:
- Use lowest effective dose (typically 25-100 mg) 2
- Ensure concurrent mood stabilizer therapy 2
- Monitor closely for early signs of activation (decreased need for sleep, increased energy, pressured speech) 1
If prescribing for depression:
- Consider alternative agents in patients with bipolar disorder 5
- If used, combine with mood stabilizer 2
- Use standard antidepressant monitoring within 1-2 weeks of initiation 5
Important Caveats
The VA/DoD guidelines advise against using trazodone for chronic insomnia due to low-quality efficacy evidence outweighed by adverse effects, though this recommendation focuses on insomnia rather than mania risk specifically. 5 Recent real-world data suggest that antidepressants overall may not significantly increase manic switching risk compared to non-antidepressant treatment in bipolar depression 6, though this should not diminish vigilance with individual patients.
The risk appears dose-dependent and context-dependent: trazodone at hypnotic doses (25-100 mg) in patients on mood stabilizers carries minimal switching risk, while antidepressant doses (150-300 mg) in unprotected bipolar patients carry meaningful risk. 2